Table. Clinical and Treatment Characteristics of the Study Patients.
| Characteristic | No. (%) |
|---|---|
| Clinical details | |
| Sex | |
| Male | 104 (49.8) |
| Female | 105 (50.2) |
| Age, median (IQR), y | 55 (48-64) |
| Cancer diagnosis | |
| Head and neck | 53 (25.4) |
| Thoracica | 80 (38.3) |
| Lower gastrointestinal and gynecological | 54 (25.8) |
| Others | 22 (10.5) |
| Hospitalized | 172 (82.3) |
| Outpatient | 37 (17.7) |
| Treatment details | |
| Radiotherapy alone | 142 (67.9) |
| Concurrent chemotherapy and RT | 67 (32.1) |
| RT details | |
| Radical | 57 (27.3) |
| Adjuvant | 99 (47.4) |
| Palliative | 53 (25.3) |
| RT regimens | |
| Conventional | 186 (89.0) |
| Hypofractionation | 23 (11.0) |
| Phase of RT at the start of study period | |
| Week 1-2 | 191 (91.4) |
| Week 3-4 | 11 (5.3) |
| Week 5-7 | 7 (3.3) |
| Treatment interruption after lockdown, No. of patients | |
| RT interruptionb | 112 (53.6) |
| Chemotherapy interruptionc | 62 |
| No. of RT sessions per day, mean (range) | |
| Before lockdown | 188 (160-209) |
| After lockdown | 12 (2-66) |
Abbreviations: IQR, interquartile range; RT, radiotherapy.
a
Includes lung, breast, and esophageal cancer patients.
b
Lockdown of Wuhan city occurred on January 23, 2020.
c
58 discontinued due to lockdown; 4 discontinued due to physician decision.